Jennifer Hall, Ph.D. - MED - DOM - Cardiology, University of Minnesota
Gold University of Minnesota M. Skip to main content.University of Minnesota.
Driven to Discover.
What's Inside


Cardiology Home

Make a Gift to Medicine


2007 Annual Report (PDF)


 

 
  Home > Faculty > Jennifer Hall, Ph.D.
 

Jennifer Hall, Ph.D.

 Dr. Hall

Associate Professor of Medicine

Director, Program in Translational Cardiovascular Genomics
Division of Cardiology, Department of Medicine
Lillehei Heart Institute
University of Minnesota Developmental Biology Center
University of Minnesota Microbiology, Immunology, and Cancer Biology Ph.D. Program
Visiting Scientist, BROAD Institute (Cambridge, MA)

Specialties

Cardiovascular genomics
Vascular biology

Ph.D.

University of California at Berkeley

Post-Doctoral Fellowships

Stanford University
Brigham and Women’s Hospital, Harvard Medical School

Research Interests and Current Research

Our interest is to identify the biological function of risk loci that are associated with cardiovascular disease and diabetes. Our laboratory incorporates genome-wide association data, clinical studies, tissue-specific gene expression from banked genotyped human specimens, and data from model organisms and cells. We are currently focused on identifying the biological function of a mutation in the gene TCF7L2 that increases risk for type 2 diabetes.

Please click here to view Dr. Hall's laboratory website.

Journal Editorial Boards

Journal of the American College of Cardiology (Associate Editor)
Circulation Research

Recent Publications
2009

Prokunina-Olsson L, Welch C, Hansson O, Adhikari N, Scott L, Usher N, Tong M,
Sprau A, Swift A, Bonnycastle L, Erdos M, He Z, Saxena R, Harmon B, Kotova O,
Hoffman E, Altshuler D, Groop L, Boehnke M, Collins F, Hall JLTissue-specific
alternative splicing of TCF7L2
. Hum Mol Genet 2009;Jul 14 (e-pub ahead of print)

Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A,
Redfield MM, Potter LR, Burnett JC Jr, Simari RD. Biodesign of a renal-protective
peptide based on alternative splicing of B-type natriuretic peptide
. Proc Natl
Acad Sci USA 2009;Jun 18 (e-pub ahead of print)

2008

Lara-Pezzi E, Felkin LE, Birks EJ, Sarathchandra P, Panse KD, George R, Hall
JL, Yacoub MH, Rosenthal N, Barton PJ. Expression of follistatin-related genes is
altered in heart failure
. Endocrinology 2008;149:5822-5827.

Orho-Melander M, Melander O, Guiducci C, Perez-Martinez P, Corella D, Roos C, Tewhey R, Rieder MJ, Hall JL, Abecasis G, Tai ES, Welch C, Arnett DK, Lyssenko V, Lindholm E, Saxena R, de Bakker PI, Burtt N, Voight BF, Hirschhorn JN, Tucker KL, Hedner T, Tuomi T, Isomaa B, Eriksson KF, Taskinen MR, Wahlstrand B, Hughes TE, Parnell LD, Lai CQ, Berglund G, Peltonen L, Vartiainen E, Jousilahti P, Havulinna AS, Salomaa V, Nilsson P, Groop L, Altshuler D, Ordovas JM, Kathiresan S. Common missense variant in the glucokinase regulatory-protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting-glucose concentrations. Diabetes 2008;57:3112-3121

Hall JL. Discovery of an intricate balance: Gene transcription, cell cycle,
and apoptosis
. Circ Res 2008;102:395-397.

Adhikari N, Rusch M, Mariash A, Li Q, Selleck SB, Hall JL. Alterations in heparan sulfate in the vessel in response to vascular injury in the mouse. J Cardiovasc Transl Res 2008;1:236-240.

2007

Hall JL, Birks EJ, Rider J, Grindle S, Barton P, Mariash A, Charles N, Dyke DB, Pagoni F, Yacoub MH. Miller LW. Molecular signature of recovery following left- ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007;5:613-627

Basi DL, Adhikari N, Mariash A, Li Q, Kao E, Mullegama SV, Hall JL. Femoral
artery neointimal hyperplasia is reduced after wire injury in Ref-1+/- mice
. Am J
Physiol Heart Circ Physiol 2007;292:H516-H521.

2006

Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW,
Birks EJ, Yacoub MH, Barton PJ. Myocardial expression of the arginine: Glycine
amidinotransferase gene is elevated in heart failure and normalized after
recovery: Potential implications for local creatine synthesis
. Circulation 2006;
114(I Suppl):I16-I20.

Adhikari N, Charles N, Lehmann U, Hall JL. Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury. Curr Atheroscler Rep 2006;8:252-260.

Wang X, Li Q, Adhikari N, Hall JL. A role for muscle LIM protein (MLP) in vascular remodeling. J Mol Cell Cardiol 2006;40:503-509.

2005

Barton PJ, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH. Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left-ventricular-assist-device and clenbuterol therapy. Circulation 2005;112(9 Suppl):I46-I50.

Birks EJ, Hall JL, Barton PJ, Grindle S, Latif N, Hardy JP, Rider JE, Banner
NR, Khaghani A, Miller LW, Yacoub MH. Gene-profiling changes in cytoskeletal
proteins during clinical recovery after left-ventricular-assist-device support
.
Circulation 2005;112(9 Suppl):I57-I64

Guan Z, Basi D, Li Q, Mariash A, Xia YF, Geng JG, Kao E, Hall JL. Loss of redox factor 1 decreases NF-kappaB activity and increases susceptibility of endothelial cells to apoptosis. Arterioscler Thromb Vasc Biol 2005;25:96-101.

 

Feedback | Notice of Privacy Practices